BU.150.710 Discovery to Market I Final Assessment Review 2026 (Qns & Ans

BU.150.710

Discovery to Market I


Final Assessment Review


(With Solutions)



2026




1

,1. Case: A nurse researcher develops a novel wound dressing that
accelerates healing.
Question: At what stage does the idea become an invention?
- A. When published in a journal
- B. When proven novel, useful, and non-obvious
- C. When marketed to hospitals
- D. When presented at a conference
Answer: B. Novel, useful, non-obvious
Rationale: Patent law defines invention by novelty, utility, and non-
obviousness.

---

2. Case: A biotech startup identifies a new biomarker for early cancer
detection.
Question: Which intellectual property protection is most appropriate?
- A. Trademark
- B. Copyright
- C. Patent
- D. Trade secret
Answer: C. Patent
Rationale: Biomarkers are patentable if novel and non-obvious.

---

3. Case: A team designs a new medical device prototype.
Question: Which regulatory body oversees approval in the U.S.?
- A. NIH
- B. FDA
- C. USPTO
- D. CDC
2

, Answer: B. FDA
Rationale: FDA regulates medical devices for safety and efficacy.

---

4. Case: A researcher wants to protect the name of a new health app.
Question: Which IP protection applies?
- A. Patent
- B. Trademark
- C. Copyright
- D. Trade secret
Answer: B. Trademark
Rationale: Trademarks protect brand names and logos.

---

5. Case: A novel drug shows promise in animal studies.
Question: What is the next step before human trials?
- A. IND submission to FDA
- B. NDA submission
- C. Phase III trial
- D. Market launch
Answer: A. IND submission
Rationale: Investigational New Drug application precedes human
testing.

---

6. Case: A researcher develops a new algorithm for patient monitoring.
Question: Which IP protection applies to the code?
- A. Copyright
- B. Patent
- C. Trademark
3